ARTICLE | Company News
Immune-Onc, University of Texas deal
April 14, 2017 7:41 PM UTC
The centers granted Immune-Onc exclusive, global rights to develop and commercialize biotherapeutics that Immune-Onc says have applications in cancer immunotherapy and other diseases. ...